Drug Patents owned by Tripoint

1. Drug name - ELEPSIA XR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8535717 TRIPOINT Pharmaceutical composition Feb, 2026

(3 years from now)

US8425938 TRIPOINT Pharmaceutical composition Feb, 2026

(3 years from now)

US8163306 TRIPOINT Oral drug delivery system Sep, 2027

(4 years from now)

US8431156 TRIPOINT Pharmaceutical composition Oct, 2027

(5 years from now)

US8470367 TRIPOINT Oral drug delivery system Oct, 2027

(5 years from now)

Drugs and Companies using LEVETIRACETAM ingredient

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
1GM TABLET, EXTENDED RELEASE;ORAL Prescription
1.5GM TABLET, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.